Jove
Visualize
Contact Us

Related Experiment Videos

Diabetic nephropathy.

Ralph Rabkin1

  • 1Department of Medicine, Division of Nephrology, Stanford University, Stanford, California, USA.

Clinical Cornerstone
|June 13, 2003
PubMed
Summary
This summary is machine-generated.

Diabetes is a growing epidemic, increasing the risk of diabetic nephropathy, a major cause of kidney failure. Early blood glucose and pressure management can slow the progression of this serious diabetic complication.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of a Home-Based Exercise Program on Indices of Physical Function and Quality of Life in Elderly Maintenance Hemodialysis Patients.

Kidney & blood pressure research·2021
Same author

Association of physical function and performance with peak VO<sub>2</sub> in elderly patients with end stage kidney disease.

Aging clinical and experimental research·2021
Same author

SOCS2 Silencing Improves Somatic Growth without Worsening Kidney Function in CKD.

American journal of nephrology·2020
Same author

A randomized controlled trial of exercise to prevent muscle mass and functional loss in elderly hemodialysis patients: Rationale, study design, and baseline sample.

Contemporary clinical trials communications·2019
Same author

Prehabilitation for kidney transplant candidates: Is it time?

Clinical transplantation·2017
Same author

Endurance exercise and growth hormone improve bone formation in young and growth-retarded chronic kidney disease rats.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2015
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Nephrology
  • Endocrinology
  • Diabetology

Background:

  • Diabetes mellitus is a global epidemic, with a significant percentage of patients developing diabetic nephropathy.
  • Diabetic nephropathy is the leading cause of end-stage renal disease (ESRD) in the United States, accounting for over 40% of new cases requiring renal replacement therapy.
  • Diabetic patients with ESRD face poorer outcomes due to prevalent comorbid conditions.

Purpose of the Study:

  • To highlight the increasing prevalence of diabetic nephropathy.
  • To emphasize the link between diabetes and end-stage renal disease.
  • To discuss strategies for slowing the progression of diabetic kidney disease.

Main Methods:

  • Review of epidemiological data on diabetes and nephropathy.

Related Experiment Videos

  • Analysis of the impact of diabetes on end-stage renal disease statistics.
  • Examination of current treatment guidelines for managing diabetic kidney disease.

    • Main Results:

    • Diabetic nephropathy affects 20% to 40% of diabetic patients.
    • Diabetes is the primary cause of ESRD in the US.
    • Comorbidities worsen outcomes for diabetic patients with ESRD.

    Conclusions:

    • Early and intensive management of blood glucose is crucial.
    • Tight blood pressure control, including ACE inhibitors and ARBs, is vital.
    • Interventions can slow the development and progression of diabetic kidney disease.